Bhubaneswar: Kalinga Institute of Medical Sciences (KIMS), a leader in performing complex heart surgeries using minimally ...

AIIMS Mangalagiri, the first All India Institute of Medical Sciences established in South India, has recently added significant advanced patient care services to its expanding clinical services, ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

Rheumatic valvular disease is responsible for aortic stenosis on occasion. In this setting, rheumatic mitral valve disease is almost always present. Some degree of aortic regurgitation generally ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.

Edwards Lifesciences Corp. EW is scheduled to report first-quarter 2025 results on April 23, after the market closes. In the ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. The condition is more common in women and younger patients ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...